EGFR-IN-192
EGFR-IN-192 is an anticancer agent. EGFR-IN-192 inhibits EGFR (IC50: 0.12 μM), downregulates the HIF-VEGF and PI3K/AKT/mTOR pathways, upregulates the tumor suppressor gene PTEN, and induces cell cycle arrest and apoptosis in tumor cells. EGFR-IN-192 exhibits antitumor activity and can be used in tumor research.
For research use only. We do not sell to patients.
- Formula: C31H24N6O3
- Molecular Weight:528.56
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
EGFR-IN-192 (Compound 7) potently inhibits the proliferation of PC-3, HePG-2 and MCF-7 cancer cells with IC50 values of 15.54 μM, 8.22 μM and 5.53 μM, respectively, and exhibits selectivity towards cancer cells compared to normal WI-38 fibroblasts[1].
EGFR-IN-192 (48 h) induces G2/M cell cycle arrest and apoptosis in MCF-7 cells[1].
EGFR-IN-192 (5.53 μM; 48 h) downregulates the gene expressions of HIF-1α and VEGF in MCF-7 cells[1].
EGFR-IN-192 (48 h) regulates the PI3K/AKT/mTOR pathway in MCF-7 cells by downregulating PI3K, AKT and mTOR, and upregulating PTEN[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:MCF-7
-
Concentration:5.53 μM
-
Incubation Time:48 h
-
Result:Significantly downregulated HIF-1α and VEGF mRNA expression compared to untreated cells.
Chemical Information
-
Molecular Weight 528.56
-
Formula C31H24N6O3
-
SMILES
O=C(N1)C(O)=C(NC(CN2)=NC3=C2C=CC=C3)C(C1=N4)=C(C5=CC=C(N(C)C)C=C5)C6=C4C7=CC=CC=C7C6=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Powered by Bioz